Search

everythinglearnresearchcommunity

for

Search:↓

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

The committee decided not to approve the drug due to low effectiveness and high risks.

Topical finasteride is promising for hair loss with minimal side effects but needs more research and approval.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Isotretinoin shows promise as a treatment for Chagas disease by effectively inhibiting key transporters in the parasite.

Combining traditional Chinese medicine with microneedles shows promise for effectively treating skin diseases with fewer side effects.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Multitarget drugs are needed to better treat complex diseases.

New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

The new cream with N-acetyl glucosamine didn't change skin color after 8 weeks.

Korean hair is typically thicker with a slower growth rate, and treatments like Dutasteride are effective for male pattern hair loss without major side effects.

AI is transforming healthcare by improving diagnostics and therapy, despite challenges with data and trust.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Using existing drugs for new treatments is cost-effective and safer.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Drug repurposing is a faster, cheaper way to develop new treatments using existing drugs.

Using computers to analyze drugs can find new uses for them, but actual experiments are needed to confirm these uses.

The tattoo machine method safely delivers an average of 1,175 µg/cm² of medication into the skin.

Using iontophoresis on minoxidil sulphate-loaded chitosan nanoparticles increases drug release but reduces its targeting to hair follicles.

Extracellular vesicles show promise for treating diseases but face challenges in development and regulation.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Getting ethical approval for research with children is important but can be complex and time-consuming, sometimes leading to the exclusion of certain age groups.